← Leaderboards
Robert D Brook
University Of Michigan At Ann Arbor
$5,169,161
Attributed
$7,031,531
Total exposure
11
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,031,531 · 11
By mechanism
R01$3,724,741 · 2
P50$2,721,955 · 1
M01$584,835 · 8
Top collaborators
- Sanjay Rajagopalan5 shared
- Masako Morishita4 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- R Clinton Webb$10,310,443
- Frank C Brosius$16,808,691
- Yuqing E Chen$44,993,151
- Akinlolu O Ojo$28,267,036
- Roger Charles Wiggins$5,948,902
Others in their field
Top investigators on “Hypertension”
- Chanza Baytop · Westat, Inc.$271,217,917
- Paula Darby Lipman · Westat, Inc.$52,914,492
- Walter N Kernan · Yale University$42,197,025
- Rohit Varma · University Of Southern California$35,266,606
- Susan S Redline · Brigham And Women'S Hospital$35,248,244
- Marlene Rabinovitch · Stanford University$34,807,202
Research focus
HypertensionBlood PressureMortalityAdultMorbidity - Disease RateSuccessEnvironmentCardiometabolismGuidelinesAir PollutionEventCardiovascular SystemChronicEvidence BaseRandomizedRisk FactorsPathway InteractionsInsightPreventCardiovascular HealthHeart FailureCitiesEffectivenessPublic Health
Grant awards (30)
ACHIEVE EPI$454,591
P50 · FY2025 · MD · contact PI
ACHIEVE P1 - HTN$460,598
P50 · FY2024 · MD · contact PI
ACHIEVE P1 - HTN$577,737
P50 · FY2023 · MD · contact PI
ACHIEVE P1 - HTN$691,226
P50 · FY2022 · MD · contact PI
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors$527,484
R01 · FY2022 · NR
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors$541,248
R01 · FY2021 · NR
ACHIEVE P1 - HTN$537,803
P50 · FY2021 · MD · contact PI
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors$572,309
R01 · FY2020 · NR
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure$251,065
R01 · FY2020 · ES
COUNTERACT Supplement--ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure$124,998
R01 · FY2020 · ES
Reducing Particulate Matter-Associated Cardiovascular Health Effects for Seniors$634,657
R01 · FY2019 · NR
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure$298,463
R01 · FY2019 · ES
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure$341,081
R01 · FY2018 · ES
ASPIRE: Air Pollution: Strategies for Personalized Intervention to Reduce Exposure$433,436
R01 · FY2017 · ES
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION$44,061
M01 · FY2007 · RR · contact PI
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION & AIR POLLUTION$20,950
M01 · FY2006 · RR · contact PI
VASCULAR TISSUE ANGIOTENSINII & ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY$3,066
M01 · FY2006 · RR · contact PI
CARDIOVASCULAR LINKAGE BETWEEN ENDOTHELIAL FUNCTION &AIR POLLUTION$146,159
M01 · FY2005 · RR
ANGIOTENSIN RECEPTOR BLOCKADE IN AGE DEPENDENT ENDOTHELIAL DYSFUNCTION$76,682
M01 · FY2005 · RR
VASCULAR TISSUE ANGIOTENSINII &ENDOTHELIAL DYSFUNCTION IN UNCOMPLICATED OBESITY$62,271
M01 · FY2005 · RR
LEPTIN IN MODULATING VASCLRTONE &ENDOTHELIAL FUNCT OBESE &NORMAL WGHT ADULT$29,849
M01 · FY2005 · RR
DEPRESSION AND ENDOTHELIAL FUNCTION - DEPEND II$514
M01 · FY2005 · RR
Vascular Tissue AngiotensinII &Endothelial Dysfunction in Uncomplicated Obesity$104,200
M01 · FY2004 · RR
Angiotensin Receptor Blockade in Age Dependent Endothelial Dysfunction$75,227
M01 · FY2004 · RR
Depression and Endothelial Function - DEPEND II$14,232
M01 · FY2004 · RR
Cardiovascular Linkage between Endothelial Function &AIR Pollution$7,624
M01 · FY2004 · RR
Lipemia induced endothelial dysfunction with/without orlistat treatment$0
M01 · FY2002 · RR
Hemodynamics, catecholamines &triglyceraide catabolism in essential hypertension$0
M01 · FY2002 · RR
Lipemia induced endothelial dysfunction with/without orlistat treatment$0
M01 · FY2000 · RR
Hemodynamics, catecholamines &triglyceraide catabolism in essential hypertension$0
M01 · FY2000 · RR